What is it about?
we present a preliminary study of the possible contribution of gut mycobiota to sub-clinical atherosclerosis in a well-characterised group of obese and non-obese subjects in association with the Framingham Risk Score (FRS) and carotid intima-media thickness (cIMT), in particular the relative abundance of the fungy M. racemosus in the gut may be a relevant biomarker for cardiovascular risk.
Featured Image
Why is it important?
It is a non invasive way to resolve a dissease
Perspectives
Manipulation of gut mycobiome communities might serve as targets in the treatment of CVDs.
MATILDE RODRIGUEZ CHACON
Institut d'investigació Sanitària Pere Virgili
Read the Original
This page is a summary of: The gut mycobiome composition is linked to carotid atherosclerosis, Beneficial Microbes, February 2018, Wageningen Academic Publishers,
DOI: 10.3920/bm2017.0029.
You can read the full text:
Contributors
The following have contributed to this page
